Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Study of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed by BV Consolidation in Patients with CD30-Positive Peripheral T-Cell Lymphomas
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.